Alchemist Limited Share Price

Equities

ALCHEM

INE964B01033

Diversified Chemicals

Market Closed - Bombay S.E. 10:00:55 13/12/2021 GMT 5-day change 1st Jan Change
3.01 INR +4.88% Intraday chart for Alchemist Limited -.--% -.--%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2019 276M 3.31M 260M Sales 2020 147M 1.75M 138M Capitalization 13.02M 156K 12.24M
Net income 2019 -496M -5.94M -466M Net income 2020 -467M -5.59M -439M EV / Sales 2019 27.6 x
Net Debt 2019 7.6B 91M 7.15B Net Debt 2020 7.65B 91.56M 7.19B EV / Sales 2020 52.3 x
P/E ratio 2019
-0.05 x
P/E ratio 2020
-0.03 x
Employees 189
Yield 2019 *
-
Yield 2020
-
Free-Float 50.34%
More Fundamentals * Assessed data
Dynamic Chart
Pombe Biosciences LLP cancelled the acquisition of Pharma Division of Alchemist Limited. CI
Alchemist Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020 CI
Alchemist Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020 CI
Alchemist Limited Provides Update on Restarting the Operations CI
Alchemist Limited Suspends Operations At All Their Offices from March 23, 2020 to March 31, 2020 CI
Alchemist Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019 CI
Alchemist Limited Announces Executive Changes CI
Pombe Biosciences LLP agreed to acquire Pharma Division of Alchemist Limited for INR 10 million. CI
Alchemist Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019 CI
Alchemist Limited Appoints Charandeep Singh Jolly as Non-Executive Director CI
Alchemist Limited Reports Earnings Results for the First Quarter Ended June 30, 2019 CI
Alchemist Limited Announces Resignation of Dinesh Kumar as Chief Financial Officer, Effective from July 02, 2019 CI
Alchemist Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Standalone and Consolidated Earnings Results for the Year Ended March 31, 2019 CI
Alchemist Limited Announces Management Changes CI
Alchemist Limited Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2018 CI
More news
3 years
2.73
Extreme 2.73
4.02
5 years
0.61
Extreme 0.61
11.69
10 years
0.61
Extreme 0.61
60.45
More quotes
Managers TitleAgeSince
Director of Finance/CFO 50 10/07/19
More insiders
Alchemist Limited is an India-based company that is engaged in the business of agriculture and allied activities consisting of floriculture and manufacturing of wire mesh for the poultry industry and trading of chemicals and pharmaceutical formulations. The Company's segments include Agri Business and Pharma, Chemical & Minerals. The Company's portfolio covers therapy areas, such as immune enhancer, antibacterial, gastrointestinal, pain reliever, anti-allergic, anti-cold, steroids, enzymes, supplements and central nervous system (CNS). The Company's brands include Anemi-XT for iron deficiency, Valcal-M for calcium deficiency, Gasease and IGTG FORTE for weak immunity. The Company's pharma unit is located at Solan, Himachal Pradesh; steel unit is located at Ropar, Punjab, and floriculture unit is located at Sirmour, Himachal Pradesh. The Company's subsidiary is Alchemist Healthcare Limited.
More about the company
  1. Stock Market
  2. Equities
  3. ALCHEM Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW